LinumLife® Flax Lignans Bioavailable

MINNEAPOLIS—In a six-month unpublished clinical pilot study conducted at the Kanda Ishin Clinic in Tokyo, five male subjects diagnosed with benign prostatic hyperplasia (BPH) were given 1 g/d of LinumLife® flax lignan (from Acatris Inc.)—an amount equivalent to 40 mg of lignans (as secoisolariciresinol diglucoside). Blood samples were taken at baseline, three months and six months, and analyzed for the enterolignans enterolactone and enterodiol. Average serum level was 115 nmol/L at baseline and then increased by three months to 145 nmol/L, a 25-percent increase. Samples taken at six months were 20 percent above baseline and seemed to reach a plateau. Jocelyn Mathern, registered dietitian and technical specialist for Acatris Inc., said, “This study demonstrates LinumLife is absorbed by the body and significantly increases serum levels of enterolactone and enterodiol, mammalian lignans which are linked with many health benefits.”

For more information, visit www.Acatris.com or Booth #4086 at SupplySide West.